A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin / 대한간학회지
The Korean Journal of Hepatology
;
: 419-422, 2007.
Article
Dans Coréen
| WPRIM
| ID: wpr-212151
ABSTRACT
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Antiviraux
/
Polyéthylène glycols
/
Ribavirine
/
Peau
/
Vascularite
/
Hépatite C chronique
/
Association de médicaments
/
Interféron alpha-2
/
Tests de la fonction hépatique
Limites du sujet:
Femelle
/
Humains
langue:
Coréen
Texte intégral:
The Korean Journal of Hepatology
Année:
2007
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS